genOway Société anonyme (EPA:ALGEN)

Market Cap	28.21M
Revenue (ttm)	27.53M
Net Income (ttm)	1.83M
Shares Out	9.22M
EPS (ttm)	n/a
PE Ratio	15.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	291
Average Volume	3,715
Open	3.000
Previous Close	3.030
Day's Range	3.000 - 3.060
52-Week Range	2.400 - 4.120
Beta	0.49
RSI	41.58
Earnings Date	Sep 19, 2025

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 141
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGEN

Financial Performance

In 2024, genOway Société anonyme's revenue was 27.53 million, an increase of 3.85% compared to the previous year's 26.51 million. Earnings were 1.83 million, an increase of 16.79%.